S. L. Chen, Y. Feng, J. Xue, S. Wang, and S. L. Wu, “Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma”, J Hematol, vol. 14, no. 6, pp. 297–306, Jan. 2025, doi: 10.14740/jh2149.